HANAAH FANNIN: Open Payments
NPI 1326680240 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 13 payments from 6 companies in 2025. Trend: 2023 $273 · 2024 $232 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $114 |
| Gilead Sciences, Inc. | 3 | $60 |
| PFIZER INC. | 2 | $52 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: QULIPTA, UBRELVY, ELIQUIS, PAXLOVID, SHINGRIX, APTIMA, Rybelsus.
Industry payments across CA — which companies pay providers there.
